title: What is the evidence that peritoneal dialysis is underutilized as an ESRD therapy?
authors.affiliation: Department of Renal Medicine, Manchester Royal Infirmary and the University of Manchester, Manchester, United Kingdom. ram.gokal@cmmc.nhs.uk
authors.forename: Ram
authors.initials: R
authors.lastname: Gokal
authors.forename: Peter G
authors.initials: PG
authors.lastname: Blake
authors.forename: Jutta
authors.initials: J
authors.lastname: Passlick-Deetjen
authors.forename: Thomas Patrick
authors.initials: TP
authors.lastname: Schaub
authors.forename: Sarah
authors.initials: S
authors.lastname: Prichard
authors.forename: John M
authors.initials: JM
authors.lastname: Burkart
mesh_terms: D002170:Canada; D003365:Costs and Cost Analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000628:therapy*; D010358:Patient Participation; D010530:Peritoneal Dialysis / Q000191:economics / Q000706:statistics & numerical data*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D015995:Prevalence; D006435:Renal Dialysis; D014481:United States